Trials / Conditions / Refractory Pancreatic Adenocarcinoma
Refractory Pancreatic Adenocarcinoma
3 registered clinical trials studyying Refractory Pancreatic Adenocarcinoma — 2 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Recruiting | TR-002 for the Treatment of Advanced, Unresectable or Metastatic Solid Tumors and Unresectable or Metastatic, NCT07189195 | University of California, Davis | Phase 1 |
| Not Yet Recruiting | JDB153 Combined With Serplulimab for Pancreatic Cancer After Standard Treatment Failure NCT07175389 | West China Hospital | Phase 1 / Phase 2 |
| Completed | SD-101, Nivolumab, and Radiation Therapy in Treating Patients With Chemotherapy-Refractory Metastatic Pancreat NCT04050085 | University of California, Davis | Phase 1 |